Emma, welcome to the Mabtech forum! Let me try to answer these questions for you:
1:
FluoroSpot and intracellular cytokine staining (ICS) in combination with flow cytometry both share the nice property of being able to detect cytokines at the single cell level. Nonetheless, FluoroSpot is generally acknowledged as being a more sensitive technique and better suited for high throughput screening. But apart from this, other important differences exist as well:
First, the FluoroSpot technique detects cytokines that have been actively secreted by the producing cells (i.e. biologically relevant cytokines). By contrast, ICS only detect cytokines that have accumulated inside of cells usually in the presence of a protein transport inhibitor such as Brefeldin A. As a result, a positive population of cytokine stained cells in flow cytometry does not necessarily translate into cytokines that would have been destined for cytokine release. In FluoroSpot this is not an issue.
Second, FluoroSpot is an “accumulative” method that captures cytokines during the entire period of incubation (24h, 48 or 72h for example). By contrast, intracellular cytokines in ICS are only captured during a limited “window” of Brefeldin A incubation, usually lasting 4-6h and often preceded by a standardized period of pre-activation (many times 16-20h). Thus, any cytokines produced prior to the addition of this Brefeldin A will not be detected using ICS. You run into the risk of simply missing important populations of cytokine producing cells, which is not the case in FluoroSpot.
Third, flow cytometry has the ability to combine the detection of intracellular cytokines with that of cell surface markers. FluoroSpot does not have this luxury. Consequently, in order to analyze a particular population, cells will have to be sorted prior to being added into the FluoroSpot wells using either a cell sorter or magnetic cell separation. In any case, this involves a much more complicated workflow compared to just staining for a couple of CD markers in FACS.
As of now, flow is able to analyze more cytokines simultaneously compared to FluoroSpot. On the other hand, multi-color flow cytometry is technically challenging to perform and are many times tide to a core-facility. FluoroSpot has been designed to be handled by any lab, anywhere.
2.
Yes, you are absolutely right! Not much difference.
The FluoroSpot assay is the natural advancement of the ELISpot assay that uses fluorescent detection instead of colorimetric. By being able to use fluorescence, the possibility of detecting two analytes simultaneously opens up a lot of interesting possibilities. Other than that, the two methods are identical.
3.
A so-called FluoroSpot reader is needed to analyze these plates at a high-throughput. Most reader companies nowadays equip their ELISpot readers with Fluorescence filters to make their machines “FluoroSpot ready”.
I hope these answers helps!
If anyone else reading this forum does not agree with my opinions, you are much welcome to register and tell me where I am wrong.